Filing Details

Accession Number:
0001479290-21-000093
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-06 19:41:39
Reporting Period:
2021-04-05
Accepted Time:
2021-04-06 19:41:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1479290 Revance Therapeutics Inc. RVNC Pharmaceutical Preparations (2834) 770551645
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1818576 Aubrey Rankin C/O Revance Therapeutics, Inc
1222 Demonbreun Street, Suite 1001
Nashville TN 37203
President, Innovation & Tech Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-05 2 $28.28 411,325 No 4 S Indirect Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 174,302 Indirect The Rankin Irrevocable Trust
Common Stock 79,776 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Rankin.
  2. These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.
  3. These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.